The Ramco Cements
About
The Ramco Cements (TRCL) is one of the top three cement producers in South India with total nameplate capacity of 12.5mtpa (0.95mtpa in West Bengal and the balance in the South). It also has operational wind farm capacity of 159MW and 157MW of CPP capacity. The company has 5 integrated cement plants 3 in Tamil Nadu, one in Andhra Pradesh and Karnataka.
Investment Argument
The Ramco Cements Limited is among the lowest cost cement producers in the south along with the most premium brands. Strong brand and higher trade segment mix aids superior pricing in core markets. De-leveraging has already started with INR500 Cr reduction in net debt over FY16 (~INR2200 Cr). With no immediate capex plan. The demand is expected to be robust in coming years on account of enhanced focus of state governments on infra spending, stabilization of newly formed states, new capital development in Amaravati and revival in small scale housing demand sponsored under various state Government schemes.
Risk
Demand in the region continued to remain sluggish due to subdued demand across sectors and delay in recovery expected on account of the formation of new states. The delay in Government plan of the smart city and housing for all will Impact the cement demand in the country. The increase in interest rate by central Government will restrict the borrowings by the infrastructural sector thus resulting in the low demand and pricing for the cement in the country.
Financials
FY
CMP
Sales
OPM(%)
EPS
PE
BVPS
PBV
EV/Sales
ROE(%)
2016 03
536.45
3595.73
24.38
23
23.32
129
4.15
4
18.17
2015 03
536.45
3604.33
15.13
10
53.6
110.
4.87
4.15
9.37
Apollo Hospitals
About
Apollo Hospitals Enterprise is one of India’s first corporate hospital chain listed players in the healthcare space. It earns revenue from various segments such as 1) Hospitals (through Joint Venture, Subsidiaries and Associates) 2) Standalone Pharmacies 3) ApolloMunich Health Insurance 4) Apollo Health & Lifestyle. Apollo owns 64 hospitals with a total bed capacity of 8985.
Investment Argument
Apollo hospitals has acquired 51% stake in a Guwahati-based hospital for ~Rs. 57 crore and expand its capacity to 220 beds thus trying to strengthen its presence in Northeast India. The company continues to earn more than 55% of its revenues from its healthcare services business. Given the planned Capex of ~Rs. 1,660 crore of which Rs 453 crore has already been deployed, it plans to add 1.350 beds to existing 40 hospitals and own additional ~7,000 beds by FY19. It recently forayed into homecare services and plans to cater to Tier-1 & Tier-2 cities by the end of FY17.
Risk
The new hospitals can take longer time to contribute. The recent acquisition of Hetero pharmacy could affect the margins as its pharmacy business is a low margin business.
FY
Financials
CMP
Sales
OPM(%)
EPS
PE
BVPS
PBV
EV/Sales
ROE(%)
2016 03
1365.60 6085.59
12.85
23.79
57.40
248
5.5
3.4
9.58
2015 03
1365.60 5178.45
13.90
24.43
55.89
227.9
5.99
3.8
10.72
Cholamandalam Inv & Fin About
Cholamandalam Investment and Finance Company Limited was incorporated in 1978 as a financial services company. The Company has now emerged as a comprehensive financial services solution provider that offers vehicle finance, business finance, home equity loans, stock broking and distribution of financial products to its customers. The Company operates from over 500 branches across India with assets under management over Rs. 30,000 crores.
Investment Argument
An improvement in Commercial Vehicle industry is slowly being witnessed which is likely to lead to higher growth for the company. The home equity (loan against property) market in India has witnessed a strong growth over the last 5 years and is expected to grow at a steady pace. The 2016 budget is focused is focusing on rural and semi-urban areas where it has more than 90% of the branches. It reported stellar Q4 results with 20% growth in revenue and 42% growth in net profits YoY basis on the back of good book growth and better fee income.
Risk
Financials
Diversification of loan book towards new business segments is needed to reduce the cyclicality in loan book pertaining to concentration in Commercial Vehicles which contribute up to 60% of loan disbursements. In case they fail to diversify, they would face considerable risk of a cyclical business downturn. Also, below normal monsoon may lead to flat growth in tractor segment. FY
CMP
Sales
OPM(%)
EPS
PE
BVPS
PBV
EV/Sales
ROE(%)
2016 03
998.80
4198.51
31.5
37.87
27.14
235.01
4.25
7.14
15.66
2015 03
998.90
3688.50
27.66
30.59
32.65
203.3
4.9
8.22
13.99
Petronet LNG
About
Petronet LNG Limited, one of the fastest growing companies in the Indian energy sector. It has set up the country's first LNG receiving and regasification terminal at Dahej, Gujarat and another terminal at Kochi, Kerala. While the Dahej terminal has a nominal capacity of 10 MMTPA, the Kochi terminal has a capacity of 5 MMTPA. The company is in the process of building a third terminal at Gangavaram, Andhra Pradesh. Formed as a Joint Venture by the Government of India to import LNG and set up LNG terminals in the country, its promoters include India's leading oil and natural gas industry players such as GAIL, ONGC, IOCL and BPCL.
Investment Argument
The price of LNG being linked to the price of oil is favorable for the importing companies as low prices lead to lower import bill which is usually denominated in foreign currency. Dahej terminal’s new capacity of 5 mntpa will be commissioned in Nov ‘16. The capacity utilization rate at Dahej plant was 116.5% in Q4 FY 16 v/s 108.4% in Q3 FY 16. The company is planning to further expand the capacity of Dahej plant by 2.5 mntpa. Kochi terminal capacity utilization is expected to reach 20% next year from a current level of 5.5%.
Risk
Kochi terminal is operating at a capacity utilization of just 5% due to delay in commissioning of Phase II of Kochi-Mangalore-Bangalore pipeline. Any change in tariffs with regards to power policy changes would impact their blended margin estimate thus exposing them to risks. Also, the delay in implementing the newly reworked contract would impact demand and hence their blended margins..
Financials
FY
CMP
Sales
OPM(%)
EPS
PE
BVPS
PBV
EV/Sales
ROE(%)
2016 03
272.50
26247.53
6.26
12.39
22.35
85.02
3.21
0.78
14.45
2015 03
272.50
39092.83
3.88
12.06
22.59
76.29
3.57
0.58
15.81
Our offering
We Offer
My Financial Advisor
My Private Banker
For Multi products Advice and online investing
For 360° Financial Management and Planning
Personalized Advice on all Investments
Comprehensive Financial Planning
Financial Goal Planning report
'0' brokerage on Shares and Mutual fund
Invest in Direct Plans of Mutual funds
Dedicated Personal Advisor for all needs
Tax planning
Income tax planning and Filing of Return*
Quarterly Review by experts
Accounting and record keeping*
Track all your Investments Online
Monthly review
Know More
Our Approach
1
2
3
4
Risk Profiling
Financial Goals
Right Portfolio
Buy/ Sell
Risk Capacity- How much Risk you can afford to take
All Financial Goals of the life
Investment Products right as per risk profile
With least Brokerage & Commission
The Inflation adjusted amount required to meet them
Portfolio which is tax efficient
With Nil hidden costs
Risk Attitude- How much Risk you want to take
Know best Investment Portfolio for you
Start Now
5 Regular Monitoring Of Portfolio Markets
Rebalance Investments required
and
when
Customized Financial Management
Wealth Creation Advice
Monthly Savings Advice
Tax Saving Investments
In case you want to invest Lump Sum
In case you want to invest On Monthly basis
In case you want to Make Tax Saving Investments
Portfolio Tracker
Goal Planning
Online Transaction
If you want to Track your investments
In case you want to Plan your Financial Goals
In case you want to Buy and Sell any product
Why AdviseSure
Simple & Easy
Paperless Process
Multiproduct
Our Simple and easy Personal Finance Tools & self-help process, ensures that you take Better control of your entire Finance in 7 Minutes , to your satisfaction.
Invest and Manage Online , on a Single Click. No need to Fill boring Physical forms and storing statements. Manage Your Finance with easy and simple back office.
We advice on almost all Financial Products except banking accounts. You can transact in all products through us. Our technology will ensure superior Experience
Cost Effective
We don't Push Products to our Customers Like Agents or Brokers, for commissions or brokerages. You can continue buying and selling with your current Broker or Agent. However you can also transact through us at substantial low Cost.
Online Access
You can manage your account from anywhere through multiple support points.
AdviseSure Investment Advisors is India’s first only Advise platform where we help individual, managing personal finance. AdviseSure Investment Advisors is part of AdviseSure Ventures Private limited. AdviseSure Investment Advisors is a SEBI registered Investment Advisor and its associate/group company empanelled with AMFI as a distributor .You can execute transactions with your banker, stock broker or agent/ financial intermediary . We also offer transaction services through various associations, at a substantially lesser cost to our clients as compared to other financial intermediaries, so that you start your financial plan with AdviseSure Investment Advisors is a safe and secure platform. Our recommendations rely on historical data. Historical/ past performance is not a guarantee of future returns. The information and views presented here are prepared by AdviseSure Investment Advisors. The information contained herein is based on our analysis and upon sources that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred based upon it. This document is solely for the personal information of the recipient. The investments discussed or recommended here may not be suitable for all investors. Investors must make their own investment decisions based on their specific investment objectives and financial position and using such independent advice, as they believe necessary. While acting upon any information or analysis mentioned here, investors may please note that neither AdviseSure Investment Advisors nor any person connected with any associated companies of AdviseSure Investment Advisors , accepts any liability arising from the use of this information and views mentioned here. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment.
AdviseSure Investment Advisors CORPORATE OFFICE : C411- Crystal Plaza, Opposite Infitni Mall, Link road, Andheri west, Mumbai 400053 -------------
Website : www.advisesure.com
Email: care@advisesure.com